"We need more": UN joins criticism of G7 vaccine pledge



* G7 to pledge 1 billion vaccine doses

* Campaigners say G7 too slow, lacks ambition

* Britain to give 100 million doses

* UK says some countries using vaccines to exert influence

By Kate Holton and Elizabeth Piper

CARBIS BAY, England, June 11 (Reuters) - A Group of Seven plan to donate 1 billion COVID-19 vaccine doses to poorer countries lacks ambition, is far too slow and shows Western leaders are not yet on top of tackling the worst public health crisis in a century, campaigners said on Friday.

While the head of the United Nations welcomed the move, even he said more was needed. Antonio Guterres warned that if people in developing countries were not inoculated quickly, the virus could mutate further and become resistant to the new vaccines.

"We need more than that," he said of the G7 plan. "We need a global vaccination plan. We need to act with a logic, with a sense of urgency, and with the priorities of a war economy, and we are still far from getting that."

U.S. President Joe Biden and British Prime Minister Boris Johnson had used the G7 summit in England to announce the donation of 500 million and 100 million vaccines respectively for the world's poorest nations.

Canada is expected to commit to sharing up to 100 million doses and other pledges may follow after Johnson urged G7 leaders to help inoculate the world's nearly 8 billion people against the coronavirus by the end of next year.

But health and anti-poverty campaigners said that, while donations were a step in the right direction, Western leaders had failed to grasp that exceptional efforts were needed to beat the virus. Help with distribution was also necessary, they said.

Former British prime minister Gordon Brown, who has been pushing for richer countries to share more of the cost of vaccinating developing countries, said the G7 pledges were more akin to "passing round the begging bowl" than a real solution.

"It's a catastrophic failure if we can't go away in the next week or two ... with a plan that actually rids the world of COVID now we've got a vaccine," he told Reuters.

Alex Harris at Wellcome, a London-based science and health charitable foundation, challenged the G7 to show the political leadership the crisis demanded.

"What the world needs is vaccines now, not later this year," he said. "We urge G7 leaders to raise their ambition."

'FAILURE'

COVID-19 has ripped through the global economy, with infections reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

The race to end a pandemic that has killed around 3.9 million people and sown social and economic destruction will feature prominently at the three-day summit which began on Friday in the English seaside resort of Carbis Bay.

British foreign minister Dominic Raab warned that other countries were using vaccines as diplomatic tools to secure influence. Britain and the United States said their donations would come with no strings attached.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated according to Johns Hopkins University data.

As most people need two vaccine doses, and possibly booster shots to tackle emerging variants, charity Oxfam said the world would need 11 billion doses to end the pandemic.

"If the best G7 leaders can manage is to donate 1 billion vaccine doses then this summit will have been a failure," Oxfam's health policy manager Anna Marriott said.

Oxfam also called on G7 leaders to support a waiver on the intellectual property behind the vaccines.

French President Emmanuel Macron has said intellectual property rights should not hinder access to vaccines during a pandemic, appearing to back Biden on the subject.

VACCINE OWNERSHIP?

But the pharmaceutical industry has opposed it, saying it would stifle innovation and do little to increase supplies. Britain, which backed Oxford-AstraZeneca's AZN.L not-for-profit shot, has said a patent waiver is not necessary.

Of the 100 million British shots, 80 million will go to the COVAX programme led by the World Health Organization (WHO) and the rest will be shared bilaterally with countries in need.

Johnson echoed Biden in calling on his fellow leaders to make similar pledges and for pharmaceutical companies to adopt the not-for-profit model during the pandemic. The U.S. donation of Pfizer PFE.N shots will be supplied at cost.

The British doses will be drawn from the stock it has already procured for its domestic programme, and will come from suppliers Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson's JNJ.N Janssen, Moderna and others.



FACTBOX-What are G7 countries pledging on vaccine doses?

GRAPHIC-COVID-19 Vaccination Tracker Link
UK's Raab: Some countries are using vaccines as a geopolitcal
tool

Canada will share up to 100 mln doses of COVID-19 vaccine with nations in need - source

Failed: UK's ex-PM Brown says G7 COVID vaccine plan offers no solution

Biden and Johnson watch on in blimp form as protesters demand G7 action

U.S. says G7 may reallocate $100 bln from IMF funds to COVID-ravaged nations

G7 leaders agreed to keep stimulus flowing for their economies



Additional reporting by Alistair Smout in London, Michelle Nichols in New York and David Ljunggren in Ottawa; Editing by Guy Faulconbridge, Alex Richardson, Emelia Sithole-Matarise and Catherine Evans

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Usamos cookies para lhe dar a melhor experiência no nosso website. Ler mais ou alterar as configurações de cookies.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.